Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational. According to the update, the investor conference is scheduled to take place virtually on Dec. 1, 2020. Trxade Group CEO Suren Ajjarapu will, beginning at 3:40 p.m. Eastern Time on the day of the conference, host a virtual presentation to investors followed by a guided question and answer session. Interested parties may visit https://ibn.fm/OWrjU to register for the webinar and access a live audio webcast and a 90-day archived replay of the conference presentation.
To view the full press release, visit https://ibn.fm/4WUpT
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group is an integrated drug procurement, delivery and health care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health care services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms: (1) the Trxade B2B trading platform with around 11,800 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
